Proteomic analysis of bladder biopsies from interstitial cystitis/bladder pain syndrome patients with and without Hunner’s lesions reveals differences in expression of inflammatory and structural proteins

被引：0
作者：
Elijah P. Ward
Sarah N. Bartolone
Michael B. Chancellor
Kenneth M. Peters
Laura E. Lamb
机构：
[1] Beaumont Health System,Department of Urology
[2] Oakland University William Beaumont School of Medicine,undefined
来源：
BMC Urology | / 20卷
关键词：
Interstitial cystitis; Proteomics; HPLC; Urinary bladder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[41]   Lipidomic analysis coupled with machine learning identifies unique urinary lipid signatures in patients with interstitial cystitis/bladder pain syndrome [J].
Iwaki, Takuya ;
Kurano, Makoto ;
Sumitani, Masahiko ;
Niimi, Aya ;
Nomiya, Akira ;
Kamei, Jun ;
Taguchi, Satoru ;
Yamada, Yuta ;
Sato, Yusuke ;
Nakamura, Masaki ;
Yamada, Daisuke ;
Minagawa, Tomonori ;
Fukuhara, Hiroshi ;
Kume, Haruki ;
Homma, Yukio ;
Akiyama, Yoshiyuki .
WORLD JOURNAL OF UROLOGY, 2025, 43 (01)
[42]   Long-term outcome and symptom improvement in patients with interstitial cystitis/bladder pain syndrome with or without regular follow-up and treatment [J].
Yeh, Hui-Ling ;
Jhang, Jia-Fong ;
Kuo, Yuh-Chen ;
Kuo, Hann-Chorng .
NEUROUROLOGY AND URODYNAMICS, 2019, 38 (07) :1985-1993
[43]   The O'Leary-Sant Interstitial Cystitis Symptom Index is a clinically useful indicator of treatment outcome in patients with interstitial cystitis/bladder pain syndrome with Hunner lesions: A post hoc analysis of the Japanese phase III trial of KRP-116D, 50% dimethyl sulfoxide solution [J].
Yoshimura, Naoki ;
Uno, Takashi ;
Sasaki, Mitsuru ;
Ohinata, Akira ;
Nawata, Shigeki ;
Ueda, Tomohiro .
INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (04) :289-296
[44]   Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study [J].
Hao Wang ;
Lucille J. Russell ;
Kathleen M. Kelly ;
Steven Wang ;
John Thipphawong .
BMC Urology, 17
[45]   Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study [J].
Wang, Hao ;
Russell, Lucille J. ;
Kelly, Kathleen M. ;
Wang, Steven ;
Thipphawong, John .
BMC UROLOGY, 2017, 17 :1-8
[46]   Cerebral Perfusion and Sensory Testing Results Differ in Interstitial Cystitis/Bladder Pain Syndrome Patients with and without Fibromyalgia: A Site-Specific MAPP Network Study [J].
Deutsch, Georg ;
Deshpande, Hrishikesh ;
Lai, H. Henry ;
Kutch, Jason J. ;
Ness, Timothy J. .
JOURNAL OF PAIN RESEARCH, 2021, 14 :3887-3895
[47]   Pathophysiology of Urothelial Dysfunction in Patients with Interstitial Cystitis/Painful Bladder Pain Syndrome: Increased Apoptosis and Decreased Junctional Protein Expression in the Urothelium due to Suburothelial Inflammation [J].
Shie, Jia-Heng ;
Kuo, Hann-Chorng .
TZU CHI MEDICAL JOURNAL, 2009, 21 (02) :103-109
[48]   Supervised machine learning algorithm identified KRT20, BATF and TP63 as biologically relevant biomarkers for bladder biopsy specimens from interstitial cystitis/bladder pain syndrome patients [J].
Kamasako, Tomohiko ;
Kaga, Kanya ;
Inoue, Ken-ichi ;
Hariyama, Masanori ;
Yamanishi, Tomonori .
INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (05) :406-412
[49]   Secondary Analysis of Interstitial Cystitis/Bladder Pain Syndrome Patients Enrolled in a Recurrent Urinary Tract Infection Prevention Study Provides a Novel Paradigm for Etio-Pathogenesis and Practical Management of This Infection Phenotype [J].
Nickel, J. Curtis ;
Cotechini, Tiziana ;
Doiron, R. Christopher .
PATHOGENS, 2024, 13 (05)
[50]   Reply from Authors re: Francisco Cruz. The Future of Pharmacologic Treatment for Bladder Pain Syndrome/Interstitial Cystitis: Lessons From a Meta-Analysis. Eur Urol 2012;61:54-55 [J].
Giannantoni, Antonella ;
Bini, Vittorio .
EUROPEAN UROLOGY, 2012, 61 (01) :56-57
12345